Is interventional bronchoscopy the first-line solution for mediastinal compression syndrome?

1 Detterbeck FC. Clinical presentation and evaluation of neuroendocrine tumors of the lung. Thoracic Surgery Clinics. 2014;24: 267–276. doi:10.1016/j.thorsurg.2014.04.002. Search in Google Scholar

2 Ulmeanu R, Tofoleanu D, Leonte D, Cordoș I, Halic E, Mihălțan F, et al. Updates in thoracic and therapeutic endoscopy. Bucharest (Romania): Carol Davila University Publishing House; 2009. p. 184. Search in Google Scholar

3 Ulmeanu R, Râjnoveanu R, Halic E, Deleanu O, Mihălţan F. The natural evolution of neoplastic bronchial lesions. Pulmonology. 2011;60(2): 93–95. Search in Google Scholar

4 Koletsis EN, Kalogeropoulou C, Prodromaki E, Kagadis GC, Katsanos K, Spiropoulos K, et al. Tumoral and non-tumoral trachea stenoses: evaluation with three-dimensional CT and virtual bronchoscopy. Journal of Cardiothoracic Surgery. 2007;2: 18. Search in Google Scholar

5 Wood DE. Bronchoscopic preparation for airway resection. Chest Surgery Clinics of North America. 2001;11(4): 735–748. Search in Google Scholar

6 Chung FT, Lin SM, Chen HC, Chou CL, Yu CT, Liu CY, et al. Factors leading to tracheobronchial self-expandable metallic stent fracture. The Journal of Thoracic and Cardiovascular Surgery. 2008;136(5): 1328–1335. Search in Google Scholar

7 Lin SM, Lin TY, Chou CL, Chen HC, Liu CY, Wang CH, et al. Metallic stent and flexible bronchoscopy without fluoroscopy for acute respiratory failure. The European Respiratory Journal. 2008;31(5): 1019–1023. Search in Google Scholar

8 Hill BB, Zweng TN, Maley RH, Charash WE, Toursarkissian B, Kearney PA. Percutaneous dilatational tracheostomy: report of 356 cases. The Journal of Trauma. 1996;41(2): 238–243. Search in Google Scholar

9 Walz MK, Peitgen K, Thürauf N, Trost HA, Wolfhard U, Sander A, et al. Percutaneous dilatational tracheostomy – early results and long-term outcome of 326 critically ill patients. Intensive Care Medicine. 1998;24(7): 685–690. Search in Google Scholar

10 Brass P, Hellmich M, Ladra A, Ladra J, Wrzosek A. Percutaneous techniques versus surgical techniques for tracheostomy. The Cochrane Database of Systematic Reviews. 2016;7(7): CD008045. Search in Google Scholar

11 Kettunen WW, Helmer SD, Haan JM. Incidence of overall complications and symptomatic tracheal stenosis is equivalent following open and percutaneous tracheostomy in the trauma patient. American Journal of Surgery. 2014;208(5): 770–774. Search in Google Scholar

12 Burningham AR, Wax MK, Andersen PE, Everts EC, Cohen JI. Metallic tracheal stents: complications associated with long-term use in the upper airway. Annals of Otology, Rhinology and Laryngology. 2002;111(4): 285–290. Search in Google Scholar

13 Eller RL, Livingston WJ 3rd, Morgan CE, Peters GE, Sillers MJ, Magnuson JS, et al. Expandable tracheal stenting for benign disease: worth the complications? The Annals of Otology, Rhinology, and Laryngology. 2006;115(4): 247–252. Search in Google Scholar

14 Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM. Bronchopulmonary neuroendocrine tumors. Cancer. 2008;113: 5–21. Search in Google Scholar

15 Fisseler-Eckhoff A, Demes M. Neuroendocrine tumors of the lung. Cancers (Basel). 2015;4: 777–798. Search in Google Scholar

16 Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Modern Pathology. 2018;31: 1770–1786. Search in Google Scholar

17 Travis WD, Brambilla E, Nicholson AG. Testing for neuroendocrine immunohistochemical markers should not be performed in poorly differentiated NSCCs in the absence of neuroendocrine morphologic features according to the 2015 WHO classification. Journal of Thoracic Oncology. 2016;11: e26–e27. Search in Google Scholar

18 Marchevsky AM, Hendifar A, Walts AE. The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence. Modern Pathology. 2018;31: 1523–1531. Search in Google Scholar

19 Garg R, Bal A, Das A, Singh N, Singh H. Proliferation marker (Ki67) in sub-categorization of neuroendocrine tumours of the lung. Türk Patoloji Dergisi. 2019;35: 15–21. doi:10.5146/tj-path.2018.01436. Search in Google Scholar

20 Travis WD, Brambilla E, Burke AP, Marx A, Nicolson AG. WHO classification of tumours of the lung, pleura, thymus and heart. 4th ed. Lyon, France: International Agency for Research on Cancer; 2015. Search in Google Scholar

21 Warren WH, Gould VE, Faber LP, Kittle CF, Memoli VA. Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants. The Journal of Thoracic and Cardiovascular Surgery. 1985;89: 819–825. Search in Google Scholar

22 Filosso PL; European Society of Thoracic Surgeons (ESTS); Neuroendocrine Tumors of The Lung Working-Group; Steering Committee; Asamura H, Brunelli A, Filosso PL, et al. Knowledge of pulmonary neuroendocrine tumors: where are we now? Thoracic Surgery Clinics. 2014;24: ix–xii. Search in Google Scholar

23 Asamura H, Kameya T, Matsuno Y, Noguchi M, Tada H, Ishikawa Y, et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. Journal of Clinical Oncology. 2006;24: 70–76. Search in Google Scholar

24 Travis WD. Advances in neuroendocrine lung tumors. Annals of Oncology. 2010;21(Suppl 7): vii65–vii71. doi:10.1093/annonc/mdq380. Search in Google Scholar

25 Wolin EM. Challenges in the diagnosis and management of well-differentiated neuroendocrine tumors of the lung (typical and atypical carcinoid): current status and future considerations. Oncologist. 2015;20: 1123–1131. Search in Google Scholar

26 Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, et al. Pulmonary neuroendocrine (carcinoid) tumors: European neuroendocrine tumor society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Annals of Oncology. 2015;26: 1604–1620. doi:10.1093/annonc/mdv041. Search in Google Scholar

27 Benzerdjeb N, Berna P, Sevestre H. GLUT1: a novel tool reflecting proliferative activity of lung neuroendocrine tumors? Pathology International. 2017;67: 32–36. doi:10.1111/pin.12486. Search in Google Scholar

28 Modlin IM, Lye KD, Kidd M. A 5 decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97: 934–959. doi:10.1002/cncr.11105. Search in Google Scholar